Skip to main content
OpenTrials
Completed

NCT Number: NCT00336076

Molecular Mechanisms and Diagnosis of Mastocytosis

Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populations is not available as it is a rare disorder. Mastocytosis in children is generally limited to the skin and follows a self limited course, while it is a disorder of the hematopoietic stem cell associated with somatic mutations of the c-kit gene in most patients with adult-onset of disease. There is no known curative therapy for most patients with systemic mastocytosis. Recent research studies identified several subtypes of disease with distinct clinical and pathologic features, however, a precise understanding of the incidence as well as molecular pathology of different disease subtypes is lacking. This study aims to examine molecular and cellular pathological aspects of disease in patients with mastocytosis and correlate findings with clinical presentation and prognosis. Patients will undergo a routine history and physical examination, and diagnostic tests will be ordered as dictated by each patient's clinical presentation. Blood and bone marrow will be obtained for diagnostic and research purposes. Genetic analysis of the c-kit gene regulating mast cell growth and differentiation will be performed. It is hoped that findings obtained from this study will help to design novel therapies for mastocytosis and other disorders in which mast cells play a critical role.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed or suspected diagnosis of mastocytosis.
  • Ability to give informed consent (by the patient or legal guardian if minor)

Exclusion criteria

  • Inability or not willing to provide informed consent.

Treatment and study plan

Collection of blood and bone marrow

Other

5-8 cc blood or bone marrow was additionally collected for analysis during diagnostic procedures. No assigned interventions.

Primary outcomes

  1. Proportion of the patients with clonal and non-clonal mast cell disorders

    Time frame: 1 week

    Patients were categorized into one of the clonal and non-clonal mast cell disorder categories after availability of diagnostic data

Secondary outcomes

  1. Proportion of KIT D816V mutation in blood, bone marrow and sorted mast cells

    Time frame: 1 week

    KIT D816V mutation was assessed in patient samples containing various proportions of neoplastic mast cells.

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Official study title

Investigation of Cellular and Molecular Pathologic Mechanisms in Mast Cell Disorders.

Important dates

Study start
2004
Primary completion
2008
Study completion
2009
First posted
Jun 12, 2006
Registry last updated
Nov 7, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.